Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Hi and hello from the Scripps Research Biotech Innovation Summit here in La Jolla. […]
There’s a boy like you in Minnesota, Yannick’s mom told him a few years ago. He has the same disease. He has the same kind of smile. Maybe you could talk? They clicked. After school […]
SAN DIEGO — When Kura Oncology decided to take aim at a protein involved in cell division and signaling, researchers reported a bonus finding: Targeting the protein, menin, didn’t just control the growth of leukemia […]
SAN DIEGO — Two years ago, Tala Fakhouri was writing AI policy at the Food and Drug Administration. Now, after leaving the FDA last summer, she’s getting a firsthand look at how the industry is […]
This was my first year attending BIO. JPM is called the “Super Bowl of biotech,” so with delegations from dozens of countries in attendance, you might say BIO is the World Cup. The big question […]
SAN DIEGO — On the exhibition floor at the annual international BIO conference in San Diego, biotech and startup executives hummed around pavilions representing member countries and states, pausing to watch World Cup games on […]
SAN DIEGO — It is an unusual time to be in the vaccine business. But in the view of those gathered here at the BIO international conference this week, it’s not altogether a bleak one. […]
You’re reading the web edition of STAT’s AI Prognosis newsletter, our subscriber-exclusive guide to artificial intelligence in health care and medicine. Sign up to get it delivered in your inbox every Wednesday. I’m writing to you from […]
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Good morning. Several of my colleagues are at the BIO conference in San Diego […]
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Good morning! Pharma companies are on a biotech buying spree, an LSD pill just […]
SAN DIEGO — Revolution Medicines is already cooking up the next iteration of RAS inhibiting drugs. At the American Association of Cancer Research annual meeting here, the company is the talk of the town for […]
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. So: Moderna says it was blindsided by the FDA, and Vinay Prasad, on its […]
SAN DIEGO — For years, Novartis was known for advancing drugs based on their scientific odds of success, regardless of the size of the market awaiting those products. But the company is betting that, in […]
Illumina became a genomics juggernaut by developing machines that could read large amounts of DNA accurately and quickly. But the company’s betting the next phase of its growth will be accelerated by helping customers better […]
Merck said Friday it would buy Cidara Therapeutics, the maker of an experimental flu therapy, in a $9.2 billion deal, as the pharma giants widens its pipeline to counter the impending revenue hit as its […]
WASHINGTON — George Tidmarsh, the Food and Drug Administration’s top regulator of drugs, has been placed on administrative leave after being accused of using his regulatory authority to inflict financial harm on a former business associate, […]
Is AI dictating patient care? What happens when your bank falls apart? And can Illumina endure some shareholder activism? We cover all that and more this week on the 250th episode of “The Readout LOUD,” […]
Illumina, the DNA sequencing giant whose stock has fallen 40% in two years, already had problems. Now it has to contend with Carl Icahn. The granddaddy of activist investors announced Monday morning that he’s taken […]
SAN DIEGO — The first time it happened, veteran real estate broker Ted Jacobs thought it was a fluke. But it didn’t take long for him to realize that the biotech industry’s demand for lab […]
Sanofi’s head of research and development, John Reed, is leaving the pharmaceutical giant to pursue a new opportunity, the company announced Monday. Reed joined Sanofi in 2018, after holding a similar position at Swiss pharma […]
Illumina, the largest maker of DNA sequencing technology, told investors exactly what they didn’t want to hear on Monday. For years, Illumina shares rose steadily as the company led the way on pushing down the […]
SAN DIEGO — Fate Therapeutics, a biotech upstart with big ambitions to use cell-based therapies to treat autoimmune diseases and cancer, is now planning to cut back on both jobs and experimental drugs after an […]
Biosplice’s bid to transform the treatment of everything from arthritis to cancer ran into a snag this week, with the San Diego biotech announcing that its experimental osteoarthritis drug failed to benefit patients in a […]
SAN DIEGO — After a steep drop in its stock price and with mounting competition from rivals, genomics giant Illumina on Thursday launched a new line of high-powered DNA sequencers, ratcheting up the race to […]
Is Illumina a victim of its own success? What makes the FDA change its mind? And how will petrodollars change biotech? We cover all that and more this week on “The Readout LOUD,” STAT’s biotech […]
For Illumina, the leading maker of DNA sequencing equipment, there was bad news and worse news Tuesday. The bad news: The European Commission said it was blocking Illumina’s $8 billion acquisition of Grail, a firm […]
SAN DIEGO — Sequencing behemoth Illumina on Thursday won its case against the Federal Trade Commission in its bid to hold onto Grail, a Bay Area early cancer detection company that the genomics giant acquired […]
SAN DIEGO — From San Diego to New Jersey, biotechs developing new forms of birth control say they’re doubling down on those efforts after Roe v. Wade was overturned — even as the Supreme Court’s […]
SAN DIEGO — More than 40 years ago, Ivor Royston, a brash young assistant professor at University of California, San Diego, made an odd pitch to scientists and pharmaceutical executives across the country: Ditch your […]
Two months after being sued by Illumina over the alleged theft of trade secrets, Bay Area biotech Guardant Health fired back this week, rejecting the DNA sequencing giant’s claims and asking a federal judge to […]
Copyright © 2026 Biotech Networks, LLC
